319 related articles for article (PubMed ID: 24931032)
1. Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?
Biessels GJ; Reijmer YD
Diabetes; 2014 Jul; 63(7):2244-52. PubMed ID: 24931032
[TBL] [Abstract][Full Text] [Related]
2. Cerebral structural and functional changes in type 1 diabetes.
Stiles MC; Seaquist ER
Minerva Med; 2010 Apr; 101(2):105-14. PubMed ID: 20467409
[TBL] [Abstract][Full Text] [Related]
3. Structural brain imaging in diabetes: a methodological perspective.
Jongen C; Biessels GJ
Eur J Pharmacol; 2008 May; 585(1):208-18. PubMed ID: 18407264
[TBL] [Abstract][Full Text] [Related]
4. Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study.
Brands AM; Biessels GJ; Kappelle LJ; de Haan EH; de Valk HW; Algra A; Kessels RP;
Dement Geriatr Cogn Disord; 2007; 23(5):343-50. PubMed ID: 17374953
[TBL] [Abstract][Full Text] [Related]
5. Brain imaging in type 2 diabetes.
Brundel M; Kappelle LJ; Biessels GJ
Eur Neuropsychopharmacol; 2014 Dec; 24(12):1967-81. PubMed ID: 24726582
[TBL] [Abstract][Full Text] [Related]
6. Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes.
de Bresser J; Reijmer YD; van den Berg E; Breedijk MA; Kappelle LJ; Viergever MA; Biessels GJ;
Dement Geriatr Cogn Disord; 2010; 30(5):381-6. PubMed ID: 20962529
[TBL] [Abstract][Full Text] [Related]
7. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
van Elderen SG; de Roos A; de Craen AJ; Westendorp RG; Blauw GJ; Jukema JW; Bollen EL; Middelkoop HA; van Buchem MA; van der Grond J
Neurology; 2010 Sep; 75(11):997-1002. PubMed ID: 20837967
[TBL] [Abstract][Full Text] [Related]
8. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study.
Verdelho A; Madureira S; Moleiro C; Ferro JM; Santos CO; Erkinjuntti T; Pantoni L; Fazekas F; Visser M; Waldemar G; Wallin A; Hennerici M; Inzitari D;
Neurology; 2010 Jul; 75(2):160-7. PubMed ID: 20625169
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive consequences of diabetes.
Ryan CM; van Duinkerken E; Rosano C
Am Psychol; 2016 Oct; 71(7):563-576. PubMed ID: 27690485
[TBL] [Abstract][Full Text] [Related]
10. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus.
Jongen C; van der Grond J; Kappelle LJ; Biessels GJ; Viergever MA; Pluim JP;
Diabetologia; 2007 Jul; 50(7):1509-16. PubMed ID: 17492428
[TBL] [Abstract][Full Text] [Related]
11. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease.
Teipel SJ; Grothe M; Lista S; Toschi N; Garaci FG; Hampel H
Med Clin North Am; 2013 May; 97(3):399-424. PubMed ID: 23642578
[TBL] [Abstract][Full Text] [Related]
12. Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes.
Brands AM; Kessels RP; Hoogma RP; Henselmans JM; van der Beek Boter JW; Kappelle LJ; de Haan EH; Biessels GJ
Diabetes; 2006 Jun; 55(6):1800-6. PubMed ID: 16731845
[TBL] [Abstract][Full Text] [Related]
13. Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes.
Tiehuis AM; Mali WP; van Raamt AF; Visseren FL; Biessels GJ; van Zandvoort MJ; Kappelle LJ; van der Graaf Y;
J Neurol Sci; 2009 Aug; 283(1-2):170-4. PubMed ID: 19268970
[TBL] [Abstract][Full Text] [Related]
14. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).
Akisaki T; Sakurai T; Takata T; Umegaki H; Araki A; Mizuno S; Tanaka S; Ohashi Y; Iguchi A; Yokono K; Ito H
Diabetes Metab Res Rev; 2006; 22(5):376-84. PubMed ID: 16506272
[TBL] [Abstract][Full Text] [Related]
15. Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-old community sample.
Kumar R; Anstey KJ; Cherbuin N; Wen W; Sachdev PS
Am J Geriatr Psychiatry; 2008 Dec; 16(12):989-98. PubMed ID: 19038898
[TBL] [Abstract][Full Text] [Related]
16. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors.
Reijmer YD; van den Berg E; de Bresser J; Kessels RP; Kappelle LJ; Algra A; Biessels GJ;
Diabetes Metab Res Rev; 2011 Feb; 27(2):195-202. PubMed ID: 21294241
[TBL] [Abstract][Full Text] [Related]
17. Cerebral microvascular lesions on high-resolution 7-Tesla MRI in patients with type 2 diabetes.
Brundel M; Reijmer YD; van Veluw SJ; Kuijf HJ; Luijten PR; Kappelle LJ; Biessels GJ;
Diabetes; 2014 Oct; 63(10):3523-9. PubMed ID: 24760137
[TBL] [Abstract][Full Text] [Related]
18. Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy.
Francis GJ; Martinez JA; Liu WQ; Xu K; Ayer A; Fine J; Tuor UI; Glazner G; Hanson LR; Frey WH; Toth C
Brain; 2008 Dec; 131(Pt 12):3311-34. PubMed ID: 19015157
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration?
Umegaki H
Age Ageing; 2010 Jan; 39(1):8-10. PubMed ID: 19917634
[TBL] [Abstract][Full Text] [Related]
20. Cognitive disorders in diabetic patients.
Koekkoek PS; Rutten GE; Biessels GJ
Handb Clin Neurol; 2014; 126():145-66. PubMed ID: 25410220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
